Precision Medicine Market in Europe to Reach USD 27 Bn by 2027 at a CAGR of 11.2% | Graphical Research

Europe precision medicine market will grow with rising geriatric population and the growing cases of age-related illnesses. The region has one of the most advanced healthcare systems in the world, enabling medical practitioners to create technologically advanced precision drugs with the help of large volumes of databases dedicated to human genomes.

As the region has a high percentage of an aging population, medical scientists can study the genetic structure and mutations in a patient and create medicines that suit their biological environment and medical needs. Innovative computing tools are being used that facilitate an in-depth study of the epigenetic changes in a patient suffering from cancer, the mechanisms that help in DNA repair, and gene regulation in cancer cells. Cancer biology is witnessing encouraging progress, which has played a key role in the creation and innovation of precision medicines for this chronic illness.

Request for a sample of this research report @ https://www.graphicalresearch.com/request/1953/sample

Precision medicine market in Europe size will go past $27 billion by 2027. Therapeutics accounted for nearly $6.5 billion revenue share of the regional market in 2020. Precision therapeutics are undergoing substantial developments to enhance their efficiency and accuracy in targeted treatments of ailments such as genetic disorders and cancer.

Healthcare professionals in the region are largely focusing on improving patient care and offering personalized medication to treat illnesses that are unique to patients. Research and development activities in therapeutics will bring in technological innovations, ultimately increasing the demand for these products.

Immunology held over 8% share of Europe precision medicine market in 2020. Immunological disorders are increasing at a substantial rate in the region. Some of the examples of these diseases include AIDS, leukemia, and other immune-complex ailments. They are either congenital or acquired and need strong doses of medication to mitigate the risk of health complications. With the help of personalized medicines, doctors can help increase the survival rate of patients suffering from these fatal disorders by studying their genetic structure and mutations and can prescribe accurate medication.

Research & academic institutes captured $2.5 billion revenue share of Europe precision medicine market in 2020. The regional governments are increasing their investments in the healthcare sector and are playing an instrumental role in developing advanced medical infrastructure for the public. These factors will be responsible for a rise in the number of medical labs and research centers in developed nations. Research institutes will stimulate the demand for precision drugs among patients as they are constantly innovating the products by keeping the client’s medical condition in mind.

Request for customization of this report @ https://www.graphicalresearch.com/request/1953/customize-this-report

Germany precision medicine market share will develop at a steady rate as the awareness surrounding the importance and benefits of using personalized drugs is growing among the people. A large part of the population is suffering from cancer. Since these products have the ability to cure severe ailments, including genetic diseases and cancer, their production and sales will see a notable hike in the nation.

Europe precision medicine market trends are expected to remain positive as prominent companies including Novartis, Quest Diagnostics, Laboratory Corporation of America Holdings, GlaxoSmithKline, Cepheid, and Myriad Genetics, among several others are producing high-quality precision solutions for their patients. With the help of research and development efforts, they can expand the advantages of these products to a great extent.

Table of Contents (ToC) of the report:

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Europe precision medicine market summary, 2016 – 2027

2.1.1    Country trends

2.1.2    Product type trends

2.1.3    Application trends

2.1.4    End-use trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 – 2027

3.3    Major factor analysis

3.3.1    Growth drivers

3.3.1.1    Advancements in cancer biology in Europe

3.3.1.2    Expanding portfolio of precision medicine drugs

3.3.1.3    Rise in online collaborative forums

3.3.1.4    Increasing adoption of gene therapy

3.3.2    Restraints & challenges

3.3.2.1    High cost of precision medicines

3.3.2.2    Violation of privacy rule and potential threat to personal health data

3.3.2.3    Stringent regulatory norms

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2020

3.7    PEST analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.graphicalresearch.com/table-of-content/1953/europe-precision-medicine-market

 

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:
Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-208-273-9852
Email: sales@graphicalresearch.com
Web: https://www.graphicalresearch.com

Leave a Reply

Your email address will not be published.